D47.1 - Chronic myeloproliferative disease
- Applicable to Chronic myeloproliferative disease
- The 2025 edition of ICD10-CM D47.1 became effective on October 1, 2024.
- This is the American ICD10-CM version of D47.1 - other international versions of ICD10 D47.1 may differ.
- D47.1 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Type 1 Excludes
- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myeloid leukemia BCR/ABL-positive (C92.1-)
- myelofibrosis NOS (D75.81)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- secondary myelofibrosis NOS (D75.81)
Billable/Specific Code
The following codes above D47.1 contain annotation back-references that may be applicable to D47.1:
- Chapter: C00-D49 - Neoplasms
- Section: D37-D48 - Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
- Category: D47 - Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com